WHO ICTRP trial
To study the efficacy and safety of product on eye health in childrens
CTRI/2022/10/046606 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/10/046606 |
|---|---|
| Public title | To study the efficacy and safety of product on eye health in childrens |
| Scientific title | To evaluate the efficacy and safety of CAEP-01 on eye strain in children with heavy screen use. |
| Primary sponsor | Vedic Lifesciences Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: H533- Other and unspecified disorders ofbinocular vision |
| Interventions | Intervention1: CAEP-01: Dose: 44 mg/day containing 4 mg of Astaxanthin Route: orally Regimen: one capsule before breakfast for 84 ± 3 days (preferably with milk/butter/ghee) Control Intervention1: Olive oil: Route: orally Regimen: one… |
| Registration date | Oct 18, 2022 |
| Target size | 64 |
| Secondary IDs | AP/220201/CAEP/ES Version: 1.0 Date: 21st June, 2022 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: